Literature DB >> 18245057

Life events and high-trait reactivity together predict psychotic symptom increases in schizophrenia.

Nancy M Docherty1, Annie St-Hilaire, Jennifer M Aakre, James P Seghers.   

Abstract

Psychotic symptoms are exacerbated by stressful life events in schizophrenia patients as a group. Some individuals appear to be more vulnerable than others in this regard. This study tested whether schizophrenia patients are highly emotionally reactive compared with controls and whether the level of trait emotional reactivity in patients influences the degree to which they respond to life stressors with exacerbations of psychosis. Schizophrenic outpatients and nonpsychiatric controls were assessed for levels of trait emotional reactivity, arousability, and trait anxiety. Severity of symptoms was also rated in the patients. Patients were then followed up 9 months later, assessed for independent stressful life events occurring during the month before the follow-up session, and reassessed for symptom levels. The patients scored higher than the control subjects on all 3 measures of reactivity at the initial assessment. At follow-up, the occurrence of potentially stressful life events predicted increases in psychotic symptoms in patients, and there was a significant interaction between level of initial trait reactivity and the occurrence of life events in the prediction of these increases. High-trait-reactive patients showed increases in psychotic symptoms in response to life stressors, whereas low-trait-reactive patients did not. These findings support the idea that patients as a group have higher than normal levels of trait reactivity and also that patients with very high levels of trait reactivity are at elevated risk of psychotic relapse under stress. Such patients might benefit particularly from interventions designed to assist them in coping with potentially stressful life events and circumstances.

Entities:  

Mesh:

Year:  2008        PMID: 18245057      PMCID: PMC2669571          DOI: 10.1093/schbul/sbn002

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  32 in total

1.  Paying attention to emotion in schizophrenia.

Authors:  S F Taylor; I Liberzon
Journal:  Br J Psychiatry       Date:  1999-01       Impact factor: 9.319

2.  Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder.

Authors:  S Doering; E Müller; W Köpcke; A Pietzcker; W Gaebel; M Linden; P Müller; F Müller-Spahn; J Tegeler; G Schüssler
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

3.  Behavioral inhibition system (BIS), behavioral activation system (BAS) and schizophrenia: relationship with psychopathology and physiology.

Authors:  Marion R M Scholten; Jack van Honk; André Aleman; René S Kahn
Journal:  J Psychiatr Res       Date:  2006-04-27       Impact factor: 4.791

4.  A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.

Authors:  S Arndt; N C Andreasen; M Flaum; D Miller; P Nopoulos
Journal:  Arch Gen Psychiatry       Date:  1995-05

5.  Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study.

Authors:  M Harrow; J R Sands; M L Silverstein; J F Goldberg
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

Review 6.  Risk factors for schizophrenia--all roads lead to dopamine.

Authors:  Marta Di Forti; Julia M Lappin; Robin M Murray
Journal:  Eur Neuropsychopharmacol       Date:  2007-03       Impact factor: 4.600

7.  Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization?

Authors:  M Marcelis; E Cavalier; J Gielen; P Delespaul; J Van Os
Journal:  Psychol Med       Date:  2004-08       Impact factor: 7.723

8.  Behavioural sensitization to daily life stress in psychosis.

Authors:  I Myin-Germeys; Ph Delespaul; J van Os
Journal:  Psychol Med       Date:  2005-05       Impact factor: 7.723

9.  Anhedonia, positive and negative affect, and social functioning in schizophrenia.

Authors:  J J Blanchard; K T Mueser; A S Bellack
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

10.  Affective reactivity of speech in schizophrenia patients and their nonschizophrenic relatives.

Authors:  N M Docherty; M J Hall; S W Gordinier
Journal:  J Abnorm Psychol       Date:  1998-08
View more
  25 in total

Review 1.  Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.

Authors:  Ruud van Winkel; Nicholas C Stefanis; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

Review 2.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Priyadurga Kodi; Anya Savransky; Peter Kochunov; Laura M Rowland; Katie L Nugent; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

4.  Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.

Authors:  Katie L Nugent; Joshua Chiappelli; Laura M Rowland; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-06-21       Impact factor: 4.905

5.  Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Symptom Data.

Authors:  Dwight Dickinson; Danielle N Pratt; Evan J Giangrande; MeiLin Grunnagle; Jennifer Orel; Daniel R Weinberger; Joseph H Callicott; Karen F Berman
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

6.  Glutamatergic Response to Heat Pain Stress in Schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Sarah Andrea Wijtenburg; Raimi Quiton; Krista Wisner; Frank Gaston; Priyadurga Kodi; Christopher Gaudiot; Peter Kochunov; Laura M Rowland; Liyi Elliot Hong
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

7.  Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; Francesca M Notarangelo; S Andrea Wijtenburg; Marian A R Thomas; Ana Pocivavsek; Aaron Jones; Krista Wisner; Peter Kochunov; Robert Schwarcz; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2018-04-18       Impact factor: 7.853

8.  Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Authors:  Joshua Chiappelli; Ana Pocivavsek; Katie L Nugent; Francesca M Notarangelo; Peter Kochunov; Laura M Rowland; Robert Schwarcz; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

9.  Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.

Authors:  Tracy Alderman; Jean Addington; Carrie Bearden; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Kristin S Cadenhead
Journal:  Early Interv Psychiatry       Date:  2014-02-27       Impact factor: 2.732

10.  Cognitive impairments, emotion, stress, and language in schizophrenia.

Authors:  James P Seghers; Nancy M Docherty
Journal:  Psychiatry Res       Date:  2009-10-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.